Hunan Hansen Pharmaceutical Co Ltd (002412) — Long-term Investment Intensity
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Long-term Investment Intensity of 29.9% as of September 2019. Long-term investments of CN¥566.09 Million represent 29.9% of total assets of CN¥1.90 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Hunan Hansen Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hunan Hansen Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2018)
This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 29.9%, reflecting long-term investments of CN¥566.09 Million against total assets of CN¥1.90 Billion CNY. Explore how well can Hunan Hansen Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hunan Hansen Pharmaceutical Co Ltd (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hunan Hansen Pharmaceutical Co Ltd from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Hunan Hansen Pharmaceutical Co Ltd.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 29.9% | CN¥537.57 Million | CN¥1.80 Billion | ▲ +3.4 pp |
| 2017 | 26.5% | CN¥450.37 Million | CN¥1.70 Billion | ▼ -0.1 pp |
| 2016 | 26.5% | CN¥444.44 Million | CN¥1.67 Billion | — |